OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar
World NewsMar 11, 2025VALBY,Denmark,March 10,2025--The Ministry of Health,Labor,and Welfare (MHLW) in Japan has granted Orphan Drug Designation (ODD) to Lundbeck\'s investigational drug,amlenetug,a potential new treatment
World NewsMar 11, 2025Production in Okinawa,Japan to be the first in Asia Pacific,targeting 200 million liters of ETJ SAF annually
World NewsMar 11, 2025CrowdStrike Falcon® Shield delivers industry-leading protection and control over SaaS misconfigurations,identities and threats – unifying hybrid identity protection
World NewsMar 11, 2025New partnerships with Beken and Robopoet showcase the future of interactive toys and connected devices
World NewsMar 11, 2025
English Morning News: Your Source for Regional News and Corporate
© English Morning News
Privacy Policy